Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors.


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 18 1 2021
pubmed: 19 1 2021
medline: 25 6 2021
Statut: ppublish

Résumé

To develop unique small-molecule inhibitors of hepatitis C virus (HCV), thiophen urea (TU) derivatives were synthesised and screened for HCV entry inhibitory activities. Among them, seven TU compounds exhibited portent anti-viral activities against genotypes 1/2 (EC

Identifiants

pubmed: 33455472
doi: 10.1080/14756366.2020.1870456
pmc: PMC7822064
doi:

Substances chimiques

Antiviral Agents 0
Thiophenes 0
Viral Envelope Proteins 0
glycoprotein E2, Hepatitis C virus 157184-61-7
Urea 8W8T17847W

Types de publication

Journal Article Retracted Publication

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-468

Commentaires et corrections

Type : RetractionIn

Références

Antimicrob Agents Chemother. 2014 May;58(5):2781-97
pubmed: 24590484
Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2136-E2145
pubmed: 28232513
Antivir Ther. 2011;16(5):695-704
pubmed: 21817191
J Hepatol. 2019 Jun;70(6):1082-1092
pubmed: 30769006
Nat Microbiol. 2020 Dec;5(12):1532-1541
pubmed: 32868923
Virol J. 2010 Jun 15;7:130
pubmed: 20550652
Front Immunol. 2018 Jun 19;9:1411
pubmed: 29971069
Eur J Med Chem. 2019 Mar 1;165:225-249
pubmed: 30685524
Cell Chem Biol. 2020 Jul 16;27(7):780-792.e5
pubmed: 32386595
Nature. 2005 Aug 18;436(7053):933-8
pubmed: 16107832
Curr Protoc Pharmacol. 2010 Jun;Chapter 9:Unit 9.12
pubmed: 22294375
Infect Genet Evol. 2007 Jan;7(1):133-44
pubmed: 16713373
Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):212-23
pubmed: 21386812
Dig Liver Dis. 2013 Jan;45(1):1-7
pubmed: 22695478
Phytomedicine. 2019 Feb;53:62-69
pubmed: 30668413
Hepatology. 2005 Oct;42(4):962-73
pubmed: 16149085
Liver Int. 2009 Jan;29 Suppl 1:74-81
pubmed: 19207969
Science. 2013 Nov 29;342(6162):1090-4
pubmed: 24288331
Pharmacol Rev. 2006 Sep;58(3):621-81
pubmed: 16968952

Auteurs

Hyung Chul Ryu (HC)

R&D Center, J2H Biotech, Suwon, Gyeonggi-do, Republic of Korea.

Marc Windisch (M)

Medicinal Chemistry, Institut Pasteur Korea, Seongnam, Gyeonggi-do, Republic of Korea.

Jee Woong Lim (JW)

R&D Center, J2H Biotech, Suwon, Gyeonggi-do, Republic of Korea.

Inhee Choi (I)

Medicinal Chemistry, Institut Pasteur Korea, Seongnam, Gyeonggi-do, Republic of Korea.

Eun Kyu Lee (EK)

Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea.

Hye Hyun Yoo (HH)

Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea.

Tae Kon Kim (TK)

College of Science and Engineering, Jungwon University, Geosan-gun, Chungbuk, Republic of Korea.

Articles similaires

Animals Hemiptera Insect Proteins Phylogeny Insecticides
Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH